United States Solid Tumors Drugs Market Report 2016

Publisher Name :
Date: 15-Sep-2016
No. of pages: 116
Inquire Before Buying

Notes:

Sales, means the sales volume of Solid Tumors Drugs

Revenue, means the sales value of Solid Tumors Drugs

This report studies sales (consumption) of Solid Tumors Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Hoffmann-La Roche

- Novartis

- Celgene

- Johnson & Johnson

- Pfizer

- BMS

- AbbVie

- AbGenomics

- ADC Therapeutics

- TG Therapeutics

- Polaris Pharmaceuticals

- Immunogen

- CTI BioPharma

- Chugai Pharmaceutical

- NewLink Genetics

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Solid Tumors Drugs in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Solid Tumors Drugs Market Report 2016

Table of Contents
United States Solid Tumors Drugs Market Report 2016
1 Solid Tumors Drugs Overview
1.1 Product Overview and Scope of Solid Tumors Drugs
1.2 Classification of Solid Tumors Drugs
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Solid Tumors Drugs
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Solid Tumors Drugs (2011-2021)
1.4.1 United States Solid Tumors Drugs Sales and Growth Rate (2011-2021)
1.4.2 United States Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
2 United States Solid Tumors Drugs Competition by Manufacturers
2.1 United States Solid Tumors Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Solid Tumors Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Solid Tumors Drugs Average Price by Manufactures (2015 and 2016)
2.4 Solid Tumors Drugs Market Competitive Situation and Trends
2.4.1 Solid Tumors Drugs Market Concentration Rate
2.4.2 Solid Tumors Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Solid Tumors Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Solid Tumors Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Solid Tumors Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Solid Tumors Drugs Price by Type (2011-2016)
3.4 United States Solid Tumors Drugs Sales Growth Rate by Type (2011-2016)
4 United States Solid Tumors Drugs Sales (Volume) by Application (2011-2016)
4.1 United States Solid Tumors Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Solid Tumors Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Solid Tumors Drugs Manufacturers Profiles/Analysis
5.1 Hoffmann-La Roche
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Solid Tumors Drugs Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Hoffmann-La Roche Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Novartis
5.2.2 Solid Tumors Drugs Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Novartis Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Celgene
5.3.2 Solid Tumors Drugs Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Celgene Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Johnson & Johnson
5.4.2 Solid Tumors Drugs Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Johnson & Johnson Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Pfizer
5.5.2 Solid Tumors Drugs Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Pfizer Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 BMS
5.6.2 Solid Tumors Drugs Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 BMS Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 AbbVie
5.7.2 Solid Tumors Drugs Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 AbbVie Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 AbGenomics
5.8.2 Solid Tumors Drugs Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 AbGenomics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 ADC Therapeutics
5.9.2 Solid Tumors Drugs Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 ADC Therapeutics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 TG Therapeutics
5.10.2 Solid Tumors Drugs Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 TG Therapeutics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Polaris Pharmaceuticals
5.12 Immunogen
5.13 CTI BioPharma
5.14 Chugai Pharmaceutical
5.15 NewLink Genetics
6 Solid Tumors Drugs Manufacturing Cost Analysis
6.1 Solid Tumors Drugs Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Solid Tumors Drugs
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Solid Tumors Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Solid Tumors Drugs Market Forecast (2016-2021)
10.1 United States Solid Tumors Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Solid Tumors Drugs Sales Forecast by Type (2016-2021)
10.3 United States Solid Tumors Drugs Sales Forecast by Application (2016-2021)
10.4 Solid Tumors Drugs Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Solid Tumors Drugs
Table Classification of Solid Tumors Drugs
Figure United States Sales Market Share of Solid Tumors Drugs by Type in 2015
Table Application of Solid Tumors Drugs
Figure United States Sales Market Share of Solid Tumors Drugs by Application in 2015
Figure United States Solid Tumors Drugs Sales and Growth Rate (2011-2021)
Figure United States Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
Table United States Solid Tumors Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Solid Tumors Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Solid Tumors Drugs Sales Share by Manufacturers
Figure 2016 Solid Tumors Drugs Sales Share by Manufacturers
Table United States Solid Tumors Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Solid Tumors Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Solid Tumors Drugs Revenue Share by Manufacturers
Table 2016 United States Solid Tumors Drugs Revenue Share by Manufacturers
Table United States Market Solid Tumors Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Solid Tumors Drugs Average Price of Key Manufacturers in 2015
Figure Solid Tumors Drugs Market Share of Top 3 Manufacturers
Figure Solid Tumors Drugs Market Share of Top 5 Manufacturers
Table United States Solid Tumors Drugs Sales by Type (2011-2016)
Table United States Solid Tumors Drugs Sales Share by Type (2011-2016)
Figure United States Solid Tumors Drugs Sales Market Share by Type in 2015
Table United States Solid Tumors Drugs Revenue and Market Share by Type (2011-2016)
Table United States Solid Tumors Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Solid Tumors Drugs by Type (2011-2016)
Table United States Solid Tumors Drugs Price by Type (2011-2016)
Figure United States Solid Tumors Drugs Sales Growth Rate by Type (2011-2016)
Table United States Solid Tumors Drugs Sales by Application (2011-2016)
Table United States Solid Tumors Drugs Sales Market Share by Application (2011-2016)
Figure United States Solid Tumors Drugs Sales Market Share by Application in 2015
Table United States Solid Tumors Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Solid Tumors Drugs Sales Growth Rate by Application (2011-2016)
Table Hoffmann-La Roche Basic Information List
Table Hoffmann-La Roche Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Hoffmann-La Roche Solid Tumors Drugs Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Solid Tumors Drugs Sales Market Share (2011-2016)
Table Celgene Basic Information List
Table Celgene Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celgene Solid Tumors Drugs Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Solid Tumors Drugs Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Solid Tumors Drugs Sales Market Share (2011-2016)
Table BMS Basic Information List
Table BMS Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table BMS Solid Tumors Drugs Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Solid Tumors Drugs Sales Market Share (2011-2016)
Table AbGenomics Basic Information List
Table AbGenomics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbGenomics Solid Tumors Drugs Sales Market Share (2011-2016)
Table ADC Therapeutics Basic Information List
Table ADC Therapeutics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table ADC Therapeutics Solid Tumors Drugs Sales Market Share (2011-2016)
Table TG Therapeutics Basic Information List
Table TG Therapeutics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table TG Therapeutics Solid Tumors Drugs Sales Market Share (2011-2016)
Table Polaris Pharmaceuticals Basic Information List
Table Polaris Pharmaceuticals Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Polaris Pharmaceuticals Solid Tumors Drugs Sales Market Share (2011-2016)
Table Immunogen Basic Information List
Table Immunogen Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Immunogen Solid Tumors Drugs Sales Market Share (2011-2016)
Table CTI BioPharma Basic Information List
Table CTI BioPharma Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table CTI BioPharma Solid Tumors Drugs Sales Market Share (2011-2016)
Table Chugai Pharmaceutical Basic Information List
Table Chugai Pharmaceutical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Chugai Pharmaceutical Solid Tumors Drugs Sales Market Share (2011-2016)
Table NewLink Genetics Basic Information List
Table NewLink Genetics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table NewLink Genetics Solid Tumors Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Solid Tumors Drugs
Figure Manufacturing Process Analysis of Solid Tumors Drugs
Figure Solid Tumors Drugs Industrial Chain Analysis
Table Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2015
Table Major Buyers of Solid Tumors Drugs
Table Distributors/Traders List
Figure United States Solid Tumors Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Solid Tumors Drugs Production Forecast by Type (2016-2021)
Table United States Solid Tumors Drugs Consumption Forecast by Application (2016-2021)
  • Healthy Diet Demand In Developed Economies To Boost Nutraceuticals
    As customers scuffle to keep up with the frantic lifestyles, the necessity for healthy nutrition rises owing to dearth of time to spend on laborious exercises.  Customers are shifting their attention to swift and healthy food behaviours. Increase in intake of beverages and functional food has offered makers of nutraceuticals with money-spinning prospects to benefit [...]
  • World Economic Forum Unveils Top 10 Emerging Technologies of 2016
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies of 2016. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or [...]
  • Siemens Adds To the Growth of Wind Power Generation Market
    Siemens has been presenting ground-breaking strategies and pioneering solutions for energy generation for an intelligent power supply globally. With an expansive portfolio and wide-ranging proficiency in wind power generation, Siemens is likely to aid in increasing the share of wind power in the US energy mix. With New Mexico’s vicinity to significant wind energy areas, [...]
  • Global Public Safety LTE Ecosystem Overview
    In view of its flourishing ecosystem, spectrum flexibility and performance metrics, LTE has emerged as the leading candidate for public safety mobile broadband networks. Public safety organizations and establishments have already begun planning to advance their networks to LTE-based public safety solutions. LTE provisions a varied range of services, from high bandwidth data services to [...]
  • RnR Market Research: Biochips Market Insights
    Growing R&D investment and subcontracting of pharmaceutical companies would lead to growth in biochips market in Asia along with an increase in the application of biochips products is estimated to improve opportunity for the global biochip market. Conversely, the high cost involved in manufacturing of biochips can be seen as a challenge for the same. [...]
  • Global 5-fluorouracil Market Professional Survey Report 2016
    Published: 28-Sep-2016        Price: US 3500 Onwards        Pages: 104
    Notes: Production, means the output of 5-fluorouracil Revenue, means the sales value of 5-fluorouracil This report studies 5-fluorouracil in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share......
  • Global Parkinsons Disease Drug Market Research Report 2016
    Published: 28-Sep-2016        Price: US 2900 Onwards        Pages: 114
    Notes: Production, means the output of Parkinsons Disease Drug Revenue, means the sales value of Parkinsons Disease Drug This report studies Parkinsons Disease Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - GSK - Novartis - Boehringer Ingelheim - Teva Pharmace......
  • United States Animal Medication Market Report 2016
    Published: 28-Sep-2016        Price: US 3800 Onwards        Pages: 117
    Notes: Sales, means the sales volume of Animal Medication Revenue, means the sales value of Animal Medication This report studies sales (consumption) of Animal Medication in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Bayer HealthCare AG (Germany) - Boehringer Ingelheim GmbH (Germany) - Ceva Sante Animale S.A. (France) - Dechra Pharmaceuticals PLC (UK) - E......
  • Global 5-fluorouracil Market Research Report 2016
    Published: 28-Sep-2016        Price: US 2900 Onwards        Pages: 104
    Notes: Production, means the output of 5-fluorouracil Revenue, means the sales value of 5-fluorouracil This report studies 5-fluorouracil in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - VHB Life Sciences Limited - Om biotec - Taj Group - Cadila Pharmaceuticals Ltd......
  • Global Artificial Tears Sales Market Report 2016
    Published: 28-Sep-2016        Price: US 4000 Onwards        Pages: 123
    Notes: Sales, means the sales volume of Artificial Tears Revenue, means the sales value of Artificial Tears This report studies sales (consumption) of Artificial Tears in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Johnson & Johnson (US) - Novartis International AG (Switzerland)......
  • Europe Immunotherapy Industry 2016 Market Research Report
    Published: 28-Sep-2016        Price: US 3600 Onwards        Pages: 135
    The Europe Immunotherapy Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Immunotherapy industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Immunotherapy market analysis is provided for the Europe markets including development trends, competitive landscape analysis, and key regions development status. Development poli......
  • Global Dental Alloys Sales 2016 Market Research Report
    Published: 28-Sep-2016        Price: US 4000 Onwards        Pages: 173
    The Global Dental Alloys Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Dental Alloys market. First, the report provides a basic overview of the Dental Alloys industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Dental Alloys mar......
  • Europe Dental Materials for Dental Bridges Market Report 2016
    Published: 28-Sep-2016        Price: US 3900 Onwards        Pages: 123
    Notes: Sales, means the sales volume of Dental Materials for Dental Bridges Revenue, means the sales value of Dental Materials for Dental Bridges This report studies sales (consumption) of Dental Materials for Dental Bridges in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Amann Girrbach......
  • Europe Dental Materials for Dental Crowns Market Report 2016
    Published: 28-Sep-2016        Price: US 3900 Onwards        Pages: 127
    Notes: Sales, means the sales volume of Dental Materials for Dental Crowns Revenue, means the sales value of Dental Materials for Dental Crowns This report studies sales (consumption) of Dental Materials for Dental Crowns in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Amann Girrbach ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs